Results 231 to 240 of about 16,096 (276)
Some of the next articles are maybe not open access.

Therapeutic Approaches and Special Considerations for Treating Molluscum Contagiosum.

Journal of Drugs in Dermatology, 2021
Molluscum contagiosum (molluscum) is a common skin condition, especially in children, yet treatment approaches by US health care practitioners vary widely.
L. Eichenfield   +4 more
semanticscholar   +1 more source

Line‐field confocal optical coherence tomography in molluscum contagiosum: a case series

Journal of the European Academy of Dermatology and Venereology, 2021
Molluscum contagiosum (MC) is a common skin infection caused by a poxvirus, generally observed in children and young, sexually active, adults. MC diagnosis is usually clinical and based on the observation of asymptomatic, small, flesh-colored papules ...
A. Verzì, G. Micali, F. Lacarrubba
semanticscholar   +1 more source

Molluscum Contagiosum

Sexually Transmitted Diseases, 1981
Molluscum contagiosum, a benign cutaneous infection of children and young adults, occurs throughout the world. Infectious virions apparently are transferred from the visible lesions to the skin of susceptible persons, either by direct contact or by fomites.
S T, Brown, J F, Nalley, S J, Kraus
openaire   +2 more sources

The molluscum contagiosum BOTE sign—Infected or inflamed?

Pediatric dermatology, 2020
Molluscum contagiosum (MC) is a common skin infection in the pediatric age group. The infection is self‐limited and manifests as discrete, umbilicated skin‐colored papules on any skin surface of the body.
Itai Gross   +7 more
semanticscholar   +1 more source

A comparative study of topical cantharidin and intralesional PPD to treat molluscum contagiosum

Journal of dermatological treatment (Print), 2020
Background: The immune system plays an important part in the clearance of molluscum contagiosum (MC) and, therefore, there has lately been a trend in using immunotherapy in MC therapy.
Fathia M Khattab, M. Nasr
semanticscholar   +1 more source

Recalcitrant molluscum contagiosum successfully treated with intralesional cidofovir in a patient with HIV/AIDS

International Journal of Dermatology, 2020
Universal access to highly active antiretroviral therapy (HAART) has noticeably decreased morbidities in patients with HIV infection. Mucocutaneous manifestations associated with human immunodeficiency virus (HIV) infection and other related ...
L. Quintana-Castanedo   +4 more
semanticscholar   +1 more source

Atypical presentation of genital molluscum contagiosum mimicking genital warts

International Journal of STD and AIDS, 2020
A man in his 20s with a history of unprotected sex with a commercial sex worker three months before presented with a solitary slowly-growing, well-defined, non-tender, oval, verrucous lesion on the mucosal aspect of his prepuce.
Sheetanshu Kumar   +3 more
semanticscholar   +1 more source

Epibulbar molluscum contagiosum

American Journal of Ophthalmology, 1998
To report a case of epibulbar conjunctival nodules from molluscum contagiosum in a patient with atopic dermatitis.A 39-year-old man with atopic dermatitis who was treated with oral prednisone was initially examined with ocular itching, foreign body sensation, and conjunctival injection of the right eye and was found to have three discrete conjunctival ...
H J, Ingraham, D B, Schoenleber
openaire   +2 more sources

Intraoral molluscum contagiosum

Oral Surgery, Oral Medicine, Oral Pathology, 1991
Molluscum contagiosum (MC) presenting as a self-limiting disease of the skin is not uncommon. To date, however, documented cases of MC of the oral cavity have been rare. A case of MC of the palate of a 52-year-old man is reported. The clinical and histopathologic features of this uncommon oral lesion are discussed, and the literature is reviewed.
S B, Whitaker   +2 more
openaire   +2 more sources

Hair regrowth and dissemination of molluscum contagiosum: two unexpected effects with dupilumab

Journal of the European Academy of Dermatology and Venereology, 2019
Dupilumab is an interleukin (IL)-4 receptor alpha antagonist that was approved by the US Food and Drug Administration in April 2017 for the treatment of adult patients with moderate-to-severe atopic dermatitis (AD) not adequately controlled with topical ...
M. Sevray   +3 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy